Protagonist Therapeutics
PTGX • NASDAQ
Protagonist Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dinesh V. Patel, with a market cap of $6.8B.
Market Cap$6.8B
Employees124.0
CEODinesh V. Patel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Protagonist Therapeutics FAQ
Common questions about Protagonist Therapeutics
Protagonist Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $12.2M.
Protagonist Therapeutics has approximately 124 employees.